{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:19:05Z","timestamp":1792675145210,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1316,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/mt.2012.247","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T09:55:04Z","timestamp":1357638904000},"page":"588-601","source":"Crossref","is-referenced-by-count":22,"title":["Preclinical Evaluation of An Anti-HCV miRNA Cluster for Treatment of HCV Infection"],"prefix":"10.1016","volume":"21","author":[{"given":"Xiao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Marcucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Anguela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda B.","family":"Couto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2012.247_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2000-9506","article-title":"Epidemiology of hepatitis C: geographic differences and temporal trends","volume":"20","author":"Wasley","year":"2000","journal-title":"Semin Liver Dis"},{"key":"10.1038\/mt.2012.247_bib2","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nature04080","article-title":"Challenges and successes in developing new therapies for hepatitis C","volume":"436","author":"De Francesco","year":"2005","journal-title":"Nature"},{"key":"10.1038\/mt.2012.247_bib3","first-page":"1032","article-title":"MicroRNA-122: a therapeutic target for hepatitis C virus (HCV) infection","volume":"3","author":"Nunnari","year":"2011","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1038\/mt.2012.247_bib4","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/S2210-7401(11)70013-4","article-title":"Chronic hepatitis C: treatments of the future","volume":"35 Suppl 2","author":"Bourli\u00e8re","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1038\/mt.2012.247_bib5","doi-asserted-by":"crossref","first-page":"30ra32","DOI":"10.1126\/scitranslmed.3000544","article-title":"Rapid emergence of protease inhibitor resistance in hepatitis C virus","volume":"2","author":"Rong","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1038\/mt.2012.247_bib6","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.23908","article-title":"Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster","volume":"52","author":"Yang","year":"2010","journal-title":"Hepatology"},{"key":"10.1038\/mt.2012.247_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(03)00801-8","article-title":"Functional siRNAs and miRNAs exhibit strand bias","volume":"115","author":"Khvorova","year":"2003","journal-title":"Cell"},{"key":"10.1038\/mt.2012.247_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0092-8674(03)00759-1","article-title":"Asymmetry in the assembly of the RNAi enzyme complex","volume":"115","author":"Schwarz","year":"2003","journal-title":"Cell"},{"key":"10.1038\/mt.2012.247_bib9","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/gt.2008.147","article-title":"Engineering and optimization of the miR-106b cluster for ectopic expression of multiplexed anti-HIV RNAs","volume":"15","author":"Aagaard","year":"2008","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.247_bib10","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/nar\/gkn109","article-title":"Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron","volume":"36","author":"Liu","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mt.2012.247_bib11","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1038\/nprot.2006.395","article-title":"Cell culture and infection system for hepatitis C virus","volume":"1","author":"Kato","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1038\/mt.2012.247_bib12","doi-asserted-by":"crossref","first-page":"12680","DOI":"10.1128\/JVI.01476-09","article-title":"Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles","volume":"83","author":"Jiang","year":"2009","journal-title":"J Virol"},{"key":"10.1038\/mt.2012.247_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0002-9440(10)63673-5","article-title":"Dynamics of hepatitis C virus replication in human liver","volume":"163","author":"Chang","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1038\/mt.2012.247_bib14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.4161\/rna.8.6.17410","article-title":"Role of pri-miRNA tertiary structure in miR-17~92 miRNA biogenesis","volume":"8","author":"Chaulk","year":"2011","journal-title":"RNA Biol"},{"key":"10.1038\/mt.2012.247_bib15","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2012.247_bib16","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"key":"10.1038\/mt.2012.247_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood-2008-10-181479","article-title":"Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy","volume":"113","author":"Niemeyer","year":"2009","journal-title":"Blood"},{"key":"10.1038\/mt.2012.247_bib18","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1128\/JVI.75.15.6969-6976.2001","article-title":"Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo","volume":"75","author":"Nakai","year":"2001","journal-title":"J Virol"},{"key":"10.1038\/mt.2012.247_bib19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1128\/AAC.50.3.899-909.2006","article-title":"Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease","volume":"50","author":"Perni","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1038\/mt.2012.247_bib20","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","article-title":"Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis","volume":"8","author":"McCarty","year":"2001","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.247_bib21","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2012.247_bib22","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.gt.3300947","article-title":"Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA","volume":"6","author":"Liu","year":"1999","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.247_bib23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature02873","article-title":"Mechanisms of gene silencing by double-stranded RNA","volume":"431","author":"Meister","year":"2004","journal-title":"Nature"},{"key":"10.1038\/mt.2012.247_bib24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"10.1038\/mt.2012.247_bib25","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1089\/hum.2008.131","article-title":"Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation","volume":"19","author":"Robbins","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2012.247_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/hgtb.2011.104","article-title":"Systemic errors in quantitative polymerase chain reaction titration of self-complementary adeno-associated viral vectors and improved alternative methods","volume":"23","author":"Fagone","year":"2012","journal-title":"Hum Gene Ther Methods"},{"key":"10.1038\/mt.2012.247_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-61779-095-9_11","article-title":"Vector characterization methods for quality control testing of recombinant adeno-associated viruses","volume":"737","author":"Wright","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1038\/mt.2012.247_bib28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1525-0016(02)00019-9","article-title":"Quantification of adeno-associated virus particles and empty capsids by optical density measurement","volume":"7","author":"Sommer","year":"2003","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.247_bib29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"10.1038\/mt.2012.247_bib30","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1073\/pnas.252758799","article-title":"RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells","volume":"100","author":"Wilson","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2012.247_bib31","first-page":"141","article-title":"RNA interference as an antiviral approach: targeting HIV-1","volume":"6","author":"Berkhout","year":"2004","journal-title":"Curr Opin Mol Ther"},{"key":"10.1038\/mt.2012.247_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virusres.2004.01.015","article-title":"Control of HIV-1 replication by RNA interference","volume":"102","author":"Lee","year":"2004","journal-title":"Virus Res"},{"key":"10.1038\/mt.2012.247_bib33","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1128\/JVI.79.3.1645-1654.2005","article-title":"Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape","volume":"79","author":"Leonard","year":"2005","journal-title":"J Virol"},{"key":"10.1038\/mt.2012.247_bib34","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1365-2893.2010.01348.x","article-title":"A perspective on modelling hepatitis C virus infection","volume":"17","author":"Guedj","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1038\/mt.2012.247_bib35","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1182\/blood-2004-10-3867","article-title":"Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2\/8-mediated, liver-directed gene therapy","volume":"105","author":"Wang","year":"2005","journal-title":"Blood"},{"key":"10.1038\/mt.2012.247_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ymthe.2005.08.017","article-title":"Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates","volume":"13","author":"Gao","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.247_bib37","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2012.247_bib38","doi-asserted-by":"crossref","first-page":"e6661","DOI":"10.1371\/journal.pone.0006661","article-title":"Focal distribution of hepatitis C virus RNA in infected livers","volume":"4","author":"Stiffler","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1038\/mt.2012.247_bib39","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1600-0854.2008.00734.x","article-title":"Exosome function: from tumor immunology to pathogen biology","volume":"9","author":"Schorey","year":"2008","journal-title":"Traffic"},{"key":"10.1038\/mt.2012.247_bib40","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1021\/pr8004887","article-title":"Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes","volume":"7","author":"Conde-Vancells","year":"2008","journal-title":"J Proteome Res"},{"key":"10.1038\/mt.2012.247_bib41","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/sj.gt.3302133","article-title":"Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo","volume":"10","author":"Wang","year":"2003","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.247_bib42","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2005-10-4035","article-title":"Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver","volume":"107","author":"Nathwani","year":"2006","journal-title":"Blood"},{"key":"10.1038\/mt.2012.247_bib43","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/sj.gt.3302134","article-title":"Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo","volume":"10","author":"McCarty","year":"2003","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.247_bib44","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/hum.2010.202","article-title":"Good manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a hemophilia B clinical trial","volume":"22","author":"Allay","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2012.247_bib45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2988","article-title":"Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1038\/mt.2012.247_bib46","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/mt.2011.219","article-title":"Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease","volume":"19","author":"McBride","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.247_bib47","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/mt.2009.277","article-title":"Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration","volume":"18","author":"Simonelli","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.247_bib48","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1182\/blood-2010-10-314518","article-title":"The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver","volume":"117","author":"Martino","year":"2011","journal-title":"Blood"},{"key":"10.1038\/mt.2012.247_bib49","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood-2003-02-0495","article-title":"Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy","volume":"102","author":"Grimm","year":"2003","journal-title":"Blood"},{"key":"10.1038\/mt.2012.247_bib50","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0016-5085(99)70185-X","article-title":"Real-time detection system for quantification of hepatitis C virus genome","volume":"116","author":"Takeuchi","year":"1999","journal-title":"Gastroenterology"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616306281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616306281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T13:33:13Z","timestamp":1539955993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616306281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1525001616306281"],"URL":"https:\/\/doi.org\/10.1038\/mt.2012.247","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}